| A mechanistic study of tumor-targeted corrole toxicity JY Hwang, J Lubow, D Chu, J Ma, H Agadjanian, J Sims, HB Gray, ... Molecular pharmaceutics 8 (6), 2233-2243, 2011 | 78 | 2011 |
| Photoexcitation of tumor-targeted corroles induces singlet oxygen-mediated augmentation of cytotoxicity JY Hwang, DJ Lubow, D Chu, J Sims, F Alonso-Valenteen, HB Gray, ... Journal of controlled release 163 (3), 368-373, 2012 | 61 | 2012 |
| Hematopoietic stem and progenitor cells are a distinct HIV reservoir that contributes to persistent viremia in suppressed patients TD Zaikos, VH Terry, NTS Kettinger, J Lubow, MM Painter, MC Virgilio, ... Cell reports 25 (13), 3759-3773. e9, 2018 | 39 | 2018 |
| Multimodality imaging in vivo for preclinical assessment of tumor-targeted doxorubicin nanoparticles JY Hwang, J Park, BJ Kang, DJ Lubow, D Chu, DL Farkas, KK Shung, ... PLoS One 7 (4), e34463, 2012 | 39 | 2012 |
| Multimodality imaging in vivo for preclinical assessment of tumor-targeted doxorubicin nanoparticles JY Hwang, J Park, BJ Kang, DJ Lubow, D Chu, DL Farkas, KK Shung, ... PLoS One 7 (4), e34463, 2012 | 39 | 2012 |
| Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes DR Collins, J Lubow, Z Lukic, M Mashiba, KL Collins PLoS pathogens 11 (7), e1005054, 2015 | 38 | 2015 |
| Investigating photoexcitation-induced mitochondrial damage by chemotherapeutic corroles using multimode optical imaging JY Hwang, DJ Lubow, JD Sims, HB Gray, A Mahammed, Z Gross, ... Journal of biomedical optics 17 (1), 015003-015003, 2012 | 32 | 2012 |
| Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages J Lubow, MC Virgilio, M Merlino, DR Collins, M Mashiba, BG Peterson, ... Elife 9, e51035, 2020 | 25 | 2020 |
| Chemotherapy targeting by DNA capture in viral protein particles H Agadjanian, D Chu, JY Hwang, S Wachsmann-Hogiu, A Rentsendorj, ... Nanomedicine 7 (3), 335-352, 2012 | 24 | 2012 |
| Vpr Is a VIP: HIV Vpr and Infected Macrophages Promote Viral Pathogenesis J Lubow, KL Collins Viruses 12 (8), 809, 2020 | 20 | 2020 |
| Concanamycin A counteracts HIV-1 Nef to enhance immune clearance of infected primary cells by cytotoxic T lymphocytes MM Painter, GE Zimmerman, MS Merlino, AW Robertson, VH Terry, X Ren, ... Proceedings of the National Academy of Sciences 117 (38), 23835-23846, 2020 | 18 | 2020 |
| Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics JD Sims, JM Taguiam, F Alonso-Valenteen, J Markman, H Agadjanian, ... Journal of Controlled Release 271, 127-138, 2018 | 12 | 2018 |
| Investigating the photosensitizer-potential of targeted gallium corrole using multimode optical imaging JY Hwang, J Lubow, D Chu, Z Gross, HB Gray, DL Farkas, ... Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques …, 2011 | 11 | 2011 |
| HER3-targeted protein chimera forms endosomolytic capsomeres and self-assembles into stealth nucleocapsids for systemic tumor homing of RNA interference in vivo F Alonso-Valenteen, S Pacheco, D Srinivas, A Rentsendorj, D Chu, ... Nucleic acids research 47 (21), 11020-11043, 2019 | 8 | 2019 |
| Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses J Lubow, LM Levoir, DK Ralph, L Belmont, M Contreras, ... PLoS pathogens 19 (10), e1011722, 2023 | 5 | 2023 |
| A Mechanistic Study of Tumor-Targeted Corrole Toxicity Mol JY Hwang, J Lubow, D Chu, J Ma, H Agadjanian, J Sims, HB Gray, ... Pharmaceutics 8, 2233-2243, 2011 | 5 | 2011 |
| HIV-1 Vpr combats the PU. 1-driven antiviral response in primary human macrophages. MC Virgilio, WM Disbennett, T Chen, J Lubow, JD Welch, KL Collins bioRxiv, 2023.03. 21.533528, 2023 | 1 | 2023 |
| Erratum: Chemotherapy targeting by DNA capture in viral protein particles (Nanomedicine (2012) 7: 3 (335-352)) H Agadjanian, D Chu, JY Hwang, S Wachsmann-Hogiu, A Rentsendorj, ... Nanomedicine 7 (8), 1275-1276, 2012 | | 2012 |
| Oligonucleotide & RNAi Therapeutics II D Chu, JY Hwang, J Lubow, A Rentsendorj, J Sims, D Nguyen, ... Molecular Therapy 20, 1, 2012 | | 2012 |
| Targeting siRNA Toxicity to HER2+ Tumors: Multi-Pronged Attack and Implications for Drug-Resistance D Chu, JY Hwang, J Lubow, A Rentsendorj, J Sims, D Nguyen, ... MOLECULAR THERAPY 20, S279-S279, 2012 | | 2012 |
Jae Youn HwangDGIST在 dgist.ac.kr 的电子邮件经过验证
